医药政策分享论坛

返回主日程
9:00 - 12:00
  • 医药政策分享论坛
  • Pharmaceutical Policy Sharing Forum
    • 主持人
  • 冯岚 , 中国医药创新促进会秘书长
  • FENG Lan , Secretary-General, China Pharmaceutical Innovation and Research Development Association
9:00 - 10:50
  • 第一阶段：领导致辞与主题报告
  • Stage 1: Leadership Speech and Keynote Speeches
9:00 - 9:10
  • 领导致辞
  • Leadership Speech
  • 宋瑞霖 中国医药创新促进会执行会长
  • SONG Ruilin , Executive President, China Pharmaceutical Innovation and Research Development Association
9:10 - 9:35
  • 主题报告1
  • Keynote Speech 1
  • 高质量发展基础上的高水平开放——药品监管国际合作和交流
  • High-level Openness Based on High-quality Development — International Cooperation and Exchange in Drug Regulation
  • 董江萍 中国食品药品国际交流中心主任
  • DONG Jiangping , Director-General, China Center for Food and Drug International Exchange
9:35 - 10:00
  • 主题报告2
  • Keynote Speech 2
  • 粤港澳大湾区药械监管创新融合与展望
  • Integration, and Prospects of Innovation of Drug and Medical Device Regulation in the Guangdong-Hong Kong-Macao Greater Bay Area
  • 王玲 广东省药品监督管理局副局长
  • WANG Ling, Deputy Director-General, Guangdong Medical Products Administration
10:00 - 10:25
  • 主题报告3
  • Keynote Speech 3
  • 澳门药械监管体系建设助力融入国家发展大局
  • Building a Regulatory System for Drug and Medical Device in Macau, Integrating it's Development into the Overall Development of China
  • 李世恩 澳门特别行政区药物监督管理局副局长
  • Lei Sai Ian , Deputy Director, Pharmaceutical Administration Bureau, Macau SAR
10:25 - 10:50
  • 主题报告4
  • Keynote Speech 4
  • 展望香港药物监管与大湾区的融合发展，发挥香港优势
  • Looking Forward to the Integrated Development of Drug Regulation in Hong Kong and the Greater Bay Area, Leveraging Hong Kong's Advantages
  • 林丰盛 香港特別行政区卫生署药物办公室总药剂师
  • LAM Fung Shing , Chief Pharmacist, Drug Office, Department of Health, Hong Kong Special Administrative Region
10:50 - 12:00
  • 第二阶段：专题讨论
  • Session II: Panel
10:50 - 12:00
  • 讨论
  • Panel
  • 推动大湾区药械监管协作，打造药械创新高水平和国际化发展
  • Promoting Drug and Medical Device Regulatory Coordination in the Greater Bay Area, Forging a High-level and Internationalized Development of Drug and Medical Device Innovation
    • 主持人
  • 蒋杰, 暨南大学粤港澳大湾区药品医疗器械真实世界研究院院长
  • JIANG Jie, Dean of the Real World Institute of Drugs and Medical Devices, Greater Bay Area, Jinan University
    • Panel嘉宾
  • 胡元佳，澳门大学药品监管科学研究中心主任
  • HU Yuanjia，Director of Centre for Pharmaceutical Regulatory Sciences, University of Macau
  • 梁云，广东省药品监督管理局行政许可处副处长
  • LIANG Yun，Deputy Director, Administration Licensing Division, Guangdong Medical Products Administration
  • 王南松，香港大学深圳医院药学部主任
  • WANG Nansong，Chief Pharmacist at the Department of Pharmacy, The University of Hong Kong Shenzhen Hospital
  • 万江，贝达药业资深副总裁兼首席运营官
  • John WAN，Senior Vice President and Chief Operations Officer, Betta Pharmaceuticals Co., Ltd.
  • 郭俊，联拓生物政府事务和市场准入副总裁
  • Martin GUO，Vice President, Government Affairs and Market Access, LianBio